These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33082837)

  • 21. [Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].
    González-García JJ; Mahillo B; Hernández S; Pacheco R; Diz S; García P; Esteban H; Arribas JR; Quereda C; Rubio R; Díez J; Moreno S; Vázquez-Rodríguez JJ
    Enferm Infecc Microbiol Clin; 2005; 23(6):340-8. PubMed ID: 15970166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy.
    Feng Z; Qiu Z; Sang Z; Lorenzo C; Glasser J
    Math Biosci; 2013 Oct; 245(2):171-87. PubMed ID: 23850537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
    Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
    Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous Viral Clearance in Sixteen HIV-Infected Patients with Chronic Hepatitis C.
    Soares J; Santos JV; Sarmento A; Costa-Pereira A
    Intervirology; 2018; 61(2):64-71. PubMed ID: 30114699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients.
    Salgüero S; Rojo D; Berenguer J; González-García J; Fernández-Rodríguez A; Brochado-Kith O; Díez C; Hontañon V; Virseda-Berdices A; Martínez J; Ibañez-Samaniego L; Llop-Herrera E; Barbas C; Resino S; Jiménez-Sousa MA;
    Liver Int; 2020 Sep; 40(9):2215-2227. PubMed ID: 32593189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.
    Tengan FM; Ibrahim KY; Dantas BP; Manchiero C; Magri MC; Bernardo WM
    BMC Infect Dis; 2016 Nov; 16(1):663. PubMed ID: 27829381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation
    Fauteux-Daniel S; Larouche A; Calderon V; Boulais J; Béland C; Ransy DG; Boucher M; Lamarre V; Lapointe N; Boucoiran I; Le Campion A; Soudeyns H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.
    Mahure SA; Bosco JA; Slover JD; Vigdorchik J; Iorio R; Schwarzkopf R
    Clin Orthop Relat Res; 2018 Feb; 476(2):356-369. PubMed ID: 29529669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
    HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.
    Bierhoff E; Fischer HP; Willsch E; Rockstroh J; Spengler U; Brackmann HH; Oldenburg J
    Virchows Arch; 1997 Apr; 430(4):271-7. PubMed ID: 9134037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM
    PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
    Younossi ZM; Stepanova M; Sulkowski M; Naggie S; Puoti M; Orkin C; Hunt SL
    J Infect Dis; 2015 Aug; 212(3):367-77. PubMed ID: 25583164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease.
    Osibogun O; Ogunmoroti O; Michos ED; Spatz ES; Olubajo B; Nasir K; Maziak W
    Rev Med Virol; 2018 Jan; 28(1):. PubMed ID: 29135056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
    Mocroft A; Lundgren J; Gerstoft J; Rasmussen LD; Bhagani S; Aho I; Pradier C; Bogner JR; Mussini C; Uberti Foppa C; Maltez F; Laguno M; Wandeler G; Falconer K; Trofimova T; Borodulina E; Jevtovic D; Bakowska E; Kase K; Kyselyova G; Haubrich R; Rockstroh JK; Peters L;
    Clin Infect Dis; 2020 May; 70(10):2131-2140. PubMed ID: 31504296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection.
    Dieterich DT
    Am J Med; 1999 Dec; 107(6B):79S-84S. PubMed ID: 10653464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.